Search - tctmd.com

Displaying 41 - 60 of 85

Sort: Relevancy | Date

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

Presenter: Sigmund Silber, Philip M. Urban, Pil Hyung Lee

October 13, 2015

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

Presentation TCT 2015

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

Presenter: Sigmund Silber, Philip M. Urban, Philippe Généreux

October 13, 2015

Presentation TCT 2015

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

Presenter: Sigmund Silber, Philip M. Urban, Robert de Winter

October 13, 2015

Presentation TCT 2015

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

Presenter: Sigmund Silber, Philip M. Urban, Wenyao Wang

October 13, 2015

Presentation TCT 2015

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Presenter: Sigmund Silber, Philip M. Urban, Evgeny Kretov

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

Presentation TCT 2015

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

Presenter: Marie-Claude Morice, Leif Thuesen, Philip M. Urban

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Alex

Presenter: Pieter C. Smits, Philip M. Urban, Dariusz Dudek

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Orsiro

Presenter: Pieter C. Smits, Philip M. Urban, Thomas Pilgrim

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Inspiron

Presenter: Pieter C. Smits, Philip M. Urban, Pedro A. Lemos

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: SinoMed BuMA

Presenter: Pieter C. Smits, Philip M. Urban, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Abluminus

Presenter: Pieter C. Smits, Philip M. Urban, Sameer I. Dani

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: DESyne BD

Presenter: Pieter C. Smits, Philip M. Urban, Tim A. Fischell, Elvin Kedhi, Karel T. Koch, Marco A. Perin, Ashok Seth, Clemens von Birgelen

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: OrbusNeich Combo

Presenter: Pieter C. Smits, Philip M. Urban, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: BioMime

Presenter: Pieter C. Smits, Philip M. Urban, Roberto Botelho

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Micell

Presenter: Pieter C. Smits, Philip M. Urban, Alexandra J. Lansky

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Firehawk

Presenter: Pieter C. Smits, Philip M. Urban, Bo Xu

October 12, 2015

Presentation TCT 2015

Why Contemporary Durable Polymers Are Not Good Enough. Do Any of the Current Bioabsorbable Polymers Make the Grade?

Presenter: Pieter C. Smits, Philip M. Urban, Renu Virmani

October 12, 2015

Advertisement

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

Device and Clinical Program Highlights: Alex

Device and Clinical Program Highlights: Orsiro

Device and Clinical Program Highlights: Inspiron

Device and Clinical Program Highlights: SinoMed BuMA

Device and Clinical Program Highlights: Abluminus

Device and Clinical Program Highlights: DESyne BD

Device and Clinical Program Highlights: OrbusNeich Combo

Device and Clinical Program Highlights: BioMime

Device and Clinical Program Highlights: Micell

Device and Clinical Program Highlights: Firehawk

Why Contemporary Durable Polymers Are Not Good Enough. Do Any of the Current Bioabsorbable Polymers Make the Grade?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content